206 related articles for article (PubMed ID: 21454225)
1. Hyperparathyroid genes: sequences reveal answers and questions.
Marx SJ
Endocr Pract; 2011; 17 Suppl 3(Suppl 3):18-27. PubMed ID: 21454225
[TBL] [Abstract][Full Text] [Related]
2. Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.
Marx SJ; Goltzman D
J Bone Miner Res; 2019 Jan; 34(1):22-37. PubMed ID: 30536424
[TBL] [Abstract][Full Text] [Related]
3. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.
Simonds WF; Robbins CM; Agarwal SK; Hendy GN; Carpten JD; Marx SJ
J Clin Endocrinol Metab; 2004 Jan; 89(1):96-102. PubMed ID: 14715834
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.
Warner J; Epstein M; Sweet A; Singh D; Burgess J; Stranks S; Hill P; Perry-Keene D; Learoyd D; Robinson B; Birdsey P; Mackenzie E; Teh BT; Prins JB; Cardinal J
J Med Genet; 2004 Mar; 41(3):155-60. PubMed ID: 14985373
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
9. Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
Marx SJ; Simonds WF; Agarwal SK; Burns AL; Weinstein LS; Cochran C; Skarulis MC; Spiegel AM; Libutti SK; Alexander HR; Chen CC; Chang R; Chandrasekharappa SC; Collins FS
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N37-43. PubMed ID: 12412776
[TBL] [Abstract][Full Text] [Related]
10. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
11. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
Cetani F; Pardi E; Ambrogini E; Lemmi M; Borsari S; Cianferotti L; Vignali E; Viacava P; Berti P; Mariotti S; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
[TBL] [Abstract][Full Text] [Related]
12. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ; Lourenço DM
Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
14. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
[TBL] [Abstract][Full Text] [Related]
15. Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
Wasserman JD; Tomlinson GE; Druker H; Kamihara J; Kohlmann WK; Kratz CP; Nathanson KL; Pajtler KW; Parareda A; Rednam SP; States LJ; Villani A; Walsh MF; Zelley K; Schiffman JD
Clin Cancer Res; 2017 Jul; 23(13):e123-e132. PubMed ID: 28674121
[TBL] [Abstract][Full Text] [Related]
16. Missense mutation in the MEN1 gene discovered through whole exome sequencing co-segregates with familial hyperparathyroidism.
Isakov O; Rinella ES; Olchovsky D; Shimon I; Ostrer H; Shomron N; Friedman E
Genet Res (Camb); 2013 Aug; 95(4):114-20. PubMed ID: 24074368
[TBL] [Abstract][Full Text] [Related]
17. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
Watanabe S; Fukumoto S
Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
[TBL] [Abstract][Full Text] [Related]
18. Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.
Agarwal SK; Mateo CM; Marx SJ
J Clin Endocrinol Metab; 2009 May; 94(5):1826-34. PubMed ID: 19141585
[TBL] [Abstract][Full Text] [Related]
19. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
Agarwal SK; Kester MB; Debelenko LV; Heppner C; Emmert-Buck MR; Skarulis MC; Doppman JL; Kim YS; Lubensky IA; Zhuang Z; Green JS; Guru SC; Manickam P; Olufemi SE; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Hum Mol Genet; 1997 Jul; 6(7):1169-75. PubMed ID: 9215689
[TBL] [Abstract][Full Text] [Related]
20. New Concepts About Familial Isolated Hyperparathyroidism.
Marx SJ
J Clin Endocrinol Metab; 2019 Sep; 104(9):4058-4066. PubMed ID: 30848815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
